IDH1 and neoplasm: Meanwhile, we stratified LGG according to the above risk factors, divided into high-risk groups (tumor recurrence, WHOIII, IDH1 wild, and VASH1 high expression) and low-risk group (primary tumor, WHOII, IDH1 mutation, and VASH1 low expression).